Einsatz von funktioneller Bildgebung zur Therapieplanung
Abstract
Translate Article 
Take Notes
Einsatz von funktioneller Bildgebung zur Therapieplanung
ReferencesShowing 10 of 54 papersIntraindividual comparison between 68Ga-PSMA-PET/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients FDG PET/CT in the Staging of Lung Cancer. Demystifying the Role of Immuno PET-CT in Non-Small Cell Lung Cancer: Clinical Value and Research Trends. The Co-IMPACT Consortium: Integrating Prostate-specific Membrane Antigen Positron Emission Tomography and Radiotherapy in Prostate Cancer Care. PSMA Ligands for PET Imaging of Prostate Cancer. PSMA-PET/MRI-Based Focal Dose Escalation in Patients with Primary Prostate Cancer Treated with Stereotactic Body Radiation Therapy (HypoFocal-SBRT): Study Protocol of a Randomized, Multicentric Phase III Trial. Targeting CAIX with [64Cu]XYIMSR-06 Small Molecular Radiotracer Enables Noninvasive PET Imaging of Malignant Glioma in U87 MG Tumor Cell Xenograft Mice. Diagnostic Accuracy of PET Tracers for the Differentiation of Tumor Progression from Treatment-Related Changes in High-Grade Glioma: A Systematic Review and Metaanalysis. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer. Immune-related [18F]FDG PET findings in patients undergoing checkpoint inhibitors treatment: correlation with clinical adverse events and prognostic implications
44
- 10.1007/s00259-020-04827-6
- Jan 1, 2020
- European Journal of Nuclear Medicine and Molecular Imaging
63
- 10.2174/1874471013666191223153755
- Nov 30, 2020
- Current Radiopharmaceuticals
2
- 10.1053/j.semnuclmed.2025.02.004
- Mar 1, 2025
- Seminars in nuclear medicine
2
- 10.1016/j.eururo.2025.01.003
- Apr 1, 2025
- European urology
185
- 10.2967/jnumed.117.191031
- Jul 7, 2017
- Journal of Nuclear Medicine
37
- 10.3390/cancers13225795
- Nov 18, 2021
- Cancers
21
- 10.1021/acs.molpharmaceut.8b01210
- Feb 25, 2019
- Molecular Pharmaceutics
57
- 10.2967/jnumed.119.233809
- Sep 20, 2019
- Journal of Nuclear Medicine
56
- 10.2967/jnumed.114.144253
- Jan 8, 2015
- Journal of Nuclear Medicine
1
- 10.1186/s40644-024-00774-9
- Sep 17, 2024
- Cancer Imaging
More from: best practice onkologieonko-aktuell Sequenztherapie des metastasierten kolorektalen Karzinoms Wichtige Studien vom ASCO 2025 Einsatz von funktioneller Bildgebung zur Therapieplanung Editorial Organerhaltende Therapie des muskelinvasiven Harnblasenkarzinoms Der erste Schritt zur kontextbewussten Medizin ist das Aufdecken der „blinden Flecken“ onko-aktuell Für Strategie bleibt da keine Zeit Wichtige Studien vom ASCO 2025
- Research Article
- 10.1007/s11654-025-00696-3
- Oct 22, 2025
- best practice onkologie
- Research Article
- 10.1007/s11654-025-00697-2
- Oct 21, 2025
- best practice onkologie
- Research Article
- 10.1007/s11654-025-00694-5
- Oct 6, 2025
- best practice onkologie
- Research Article
- 10.1007/s11654-025-00689-2
- Oct 1, 2025
- best practice onkologie
- Research Article
- 10.1007/s11654-025-00692-7
- Oct 1, 2025
- best practice onkologie
- Research Article
- 10.1007/s11654-025-00685-6
- Sep 22, 2025
- best practice onkologie
- Research Article
- 10.1007/s11654-025-00691-8
- Sep 19, 2025
- best practice onkologie
- Research Article
- 10.1007/s11654-025-00693-6
- Sep 19, 2025
- best practice onkologie
- Research Article
- 10.1007/s11654-025-00687-4
- Sep 12, 2025
- best practice onkologie
- Research Article
- 10.1007/s11654-025-00684-7
- Sep 9, 2025
- best practice onkologie
- Ask R Discovery
- Chat PDF
AI summaries and top papers from 250M+ research sources.